These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 10801249)
21. Reversal of morphine-induced urinary retention after methylnaltrexone. Garten L; Bührer C Arch Dis Child Fetal Neonatal Ed; 2012 Mar; 97(2):F151-3. PubMed ID: 22034654 [TBL] [Abstract][Full Text] [Related]
22. The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health. Wong BS; Rao AS; Camilleri M; Manabe N; McKinzie S; Busciglio I; Burton DD; Ryks M; Zinsmeister AR Aliment Pharmacol Ther; 2010 Oct; 32(7):884-93. PubMed ID: 20839388 [TBL] [Abstract][Full Text] [Related]
23. ADL 8-2698, a trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia. Liu SS; Hodgson PS; Carpenter RL; Fricke JR Clin Pharmacol Ther; 2001 Jan; 69(1):66-71. PubMed ID: 11180040 [TBL] [Abstract][Full Text] [Related]
24. Dose-related antagonism of the emetic effect of morphine by methylnaltrexone in dogs. Foss JF; Bass AS; Goldberg LI J Clin Pharmacol; 1993 Aug; 33(8):747-51. PubMed ID: 8408737 [TBL] [Abstract][Full Text] [Related]
25. Reversal of morphine-induced catalepsy in the rat by narcotic antagonists and their quaternary derivatives. Brown DR; Robertson MJ; Goldberg LI Neuropharmacology; 1983 Mar; 22(3):317-21. PubMed ID: 6682490 [TBL] [Abstract][Full Text] [Related]
26. Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects. Yuan CS Ann Pharmacother; 2007 Jun; 41(6):984-93. PubMed ID: 17504835 [TBL] [Abstract][Full Text] [Related]
27. Evidence for a peripheral action of thyrotropin releasing hormone on gastrointestinal transit in mice. Bansinath M; Bhargava HN Neuropharmacology; 1988 Apr; 27(4):433-7. PubMed ID: 2901674 [TBL] [Abstract][Full Text] [Related]
29. Effects of methylnaltrexone on morphine-induced inhibition of contraction in isolated guinea-pig ileum and human intestine. Yuan CS; Foss JF; Moss J Eur J Pharmacol; 1995 Mar; 276(1-2):107-11. PubMed ID: 7781680 [TBL] [Abstract][Full Text] [Related]
30. Antagonism of heroin and morphine self-administration in rats by the morphine-6beta-glucuronide antagonist 3-O-methylnaltrexone. Walker JR; King M; Izzo E; Koob GF; Pasternak GW Eur J Pharmacol; 1999 Oct; 383(2):115-9. PubMed ID: 10585524 [TBL] [Abstract][Full Text] [Related]
31. Methylnaltrexone: its pharmacological effects alone and effects on morphine in healthy volunteers. Zacny JP; Wroblewski K; Coalson DW Psychopharmacology (Berl); 2015 Jan; 232(1):63-73. PubMed ID: 24871705 [TBL] [Abstract][Full Text] [Related]
32. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa. Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601 [TBL] [Abstract][Full Text] [Related]
33. Dose-related effects of controlled release dihydrocodeine on oro-cecal transit and pupillary light reflex. A study in human volunteers. Freye E; Baranowski J; Latasch L Arzneimittelforschung; 2001 Jan; 51(1):60-6. PubMed ID: 11215327 [TBL] [Abstract][Full Text] [Related]
34. 6beta-naltrexol preferentially antagonizes opioid effects on gastrointestinal transit compared to antinociception in mice. Yancey-Wrona JE; Raymond TJ; Mercer HK; Sadée W; Bilsky EJ Life Sci; 2009 Sep; 85(11-12):413-20. PubMed ID: 19583969 [TBL] [Abstract][Full Text] [Related]
35. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus. Neyens R; Jackson KC J Pain Palliat Care Pharmacother; 2007; 21(2):27-33. PubMed ID: 17844725 [TBL] [Abstract][Full Text] [Related]
36. Methylnaltrexone crosses the blood-brain barrier and attenuates centrally-mediated behavioral effects of morphine and oxycodone in mice. Walentiny DM; Komla E; Moisa LT; Mustafa MA; Poklis JL; Akbarali HI; Beardsley PM Neuropharmacology; 2021 Mar; 185():108437. PubMed ID: 33316279 [TBL] [Abstract][Full Text] [Related]
37. Methylnaltrexone antagonizes opioid-mediated enhancement of HIV infection of human blood mononuclear phagocytes. Ho WZ; Guo CJ; Yuan CS; Douglas SD; Moss J J Pharmacol Exp Ther; 2003 Dec; 307(3):1158-62. PubMed ID: 14560041 [TBL] [Abstract][Full Text] [Related]
38. Central vs. peripheral mediation of opioid effects on alcohol consumption in free-feeding rats. Linseman MA Pharmacol Biochem Behav; 1989 Jun; 33(2):407-13. PubMed ID: 2813479 [TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of methylnaltrexone in shortening the duration of postoperative ileus following segmental colectomy: results of two randomized, placebo-controlled phase 3 trials. Yu CS; Chun HK; Stambler N; Carpenito J; Schulman S; Tzanis E; Randazzo B Dis Colon Rectum; 2011 May; 54(5):570-8. PubMed ID: 21471758 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of methylnaltrexone versus naloxone for reversal of morphine-induced depression of hypoxic ventilatory response. Amin HM; Sopchak AM; Foss JF; Esposito BF; Roizen MF; Camporesi EM Anesth Analg; 1994 Apr; 78(4):701-5. PubMed ID: 8135389 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]